- ￥304 - 5500
- MedChemExpress(MCE)
- 美国
- HY-12203
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
1462249-75-7
- 规格：
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg/100 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥578.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥304.0 |
| 规格： | 5 mg | 产品价格： | ￥800.0 |
| 规格： | 10 mg | 产品价格： | ￥1300.0 |
| 规格： | 25 mg | 产品价格： | ￥2263.0 |
| 规格： | 50 mg | 产品价格： | ￥3500.0 |
| 规格： | 100 mg | 产品价格： | ￥5500.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
PFK-158
CAS No. : 1462249-75-7
MCE 国际站：PFK-158
产品活性：PFK-158 是一种有效的，选择性的 PFKFB3 抑制剂，IC50 值为 137 nM。PFK-158 可减少癌细胞中葡萄糖的摄取，ATP 的产生，乳酸的释放，并诱导细胞凋亡和自噬。PFK-158 具有广泛的抗肿瘤活性。PFK-158 还可以增强 Colistin 对细菌的抵抗力。
In Vitro: PFK-158 (10 µM ; 24 hours; OV2008 and C13 cells) combined with Carboplatin (CBPt; 77-453 μM) results in significant increase in apoptosis in C13 (45%) and OV2008 cells (24.6%).
PFK-158 (0-10 µM ; 24 hours; C13 and HeyA8MDR cells) treatment results in a dose-dependent decrease in p-PFKFB3, p-cPLA2 and lipid droplet (LD) levels.
PFK-158 (10 μM; 24 hours) has synergistic anti-proliferative effects in vitro when combined with Cisplatin in C13 and HeyA8MDR cells compared to OV2008 and HeyA8, respectively.
PFK-158 (0‐10 μM; 24 h) treatment shows a dose-dependent downregulation of p62/SQSTM1 and upregulation of LC3BII, two markers of autophagy induction, in both C13 and HeyA8MDR cells. PFK-158 treatment also reduces the numbers of LDs.
In Vivo: PFK-158 (15 mg/kg; intraperitoneal injection; once a week; for 4 weeks; female athymic nude mice) plus CBPt (51 mg/kg) treatment leads to significantly enhanced antitumor activity in a gynecologic cancer mouse model.
相关产品：Clinical Compound Library Plus | Bioactive Compound Library Plus | Apoptosis Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Autophagy Compound Library | Antibacterial Compound Library | Anti-Cancer Metabolism Compound Library | Heterocyclic Compound Library | Highly Selective Activators Library | Cell Death Library | MG-132 | Doxorubicin hydrochloride | Bafilomycin A1 | LY294002 | Tamoxifen | Paclitaxel | Y-27632 | Acetylcysteine | Angiotensin II human | 2-Deoxy-D-glucose | Staurosporine | SB-431542 | Actinomycin D | Deferoxamine mesylate | Bortezomib | 5-Fluorouracil | Trametinib | Sorafenib | Oxaliplatin | Gemcitabine | Temozolomide | Rotenone | Mdivi-1 | Elesclomol | Ruxolitinib | Decitabine | SP600125 | MK-2206 dihydrochloride | Etoposide | Monomethyl auristatin E
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Onodera pp. 61 - 74 4. The Reference Point Method in Primer Design Thomas Kämpke pp. 75 - 92 5. PCR Primer Design Using Statistical Modeling Anton Yuryev pp. 93 - 104 6. Developing a Statistical Model for Primer Design Jianping Huang
红细胞酶缺陷为遗传性溶血的三大原因之一。已知至少有19种酶缺陷可引起溶血性贫血。红细胞酶缺陷所致的溶血性贫血，除葡萄糖6磷酸脱氢酶（G6PD)缺陷较多见，丙酮酸激酶（PK)亦可见外，余均少见。 红细胞能量来源主要是通过糖代谢生成ATP。红细胞糖代谢主要有无氧糖酵解途径（EMP)和己糖单磷酸旁路（HMP)两种。前者有13种酶参与，已知其中有10种酶缺陷可以引起溶血性贫血（如 HK，GPI，PFK，ALD，TPI，PGK，DPGM，PK等)。后者有6种酶参与，均有因遗传
Isolation of Melanoma Tumor-Initiating Cells from Surgical Tissues
during the course of its progression or relapse (Ailles and Weissman, Curr Opin Biotechnol 18:460–466, 2007; Chan et al., Proc Natl Acad Sci U S A 106:14016–14021, 2009; D’Angelo and Wicha, Prog Mol Biol Transl Sci 95:113–158, 2010; O’Brien, Semin Radiat Oncol 19:71
技术资料暂无技术资料 索取技术资料
